THERAZONE ApS: Financial statements 2023
CVR: 27255574
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
THERAZONE ApS (CVR 27255574) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -198,960 and a net result of DKK 2,462,806 compared with DKK -2,178,530 the year before. Equity in the 2023 report amounted to DKK 44,838,296. The solvency ratio was 98.9%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -198,960
- Profit/Loss
- DKK 2,462,806
- Equity
- DKK 44,838,296
- Total Assets
- DKK 45,355,568
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -199 t. | 2.5 mio. | 44.8 mio. | 2 |
| 2022 | - | -83 t. | -2.2 mio. | 42.5 mio. | 2 |
| 2021 | - | -102 t. | 1.4 mio. | 44.8 mio. | 1 |
| 2020 | - | -115 t. | 9.2 mio. | 43.5 mio. | - |
| 2019 | - | 13 t. | 7.7 mio. | 34.4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
THERAZONE ApS has published its annual report for 2022. Gross profit came to DKK -82,900, and the net result was DKK -2,178,530.
About THERAZONE ApS
THERAZONE ApS is a Danish company of the type Anpartsselskab based in Dragør, founded in 2003. The company is registered under the industry Investering for egen regning. The management consists of Thomas Magnussen. The company is owned by Thomas Magnussen. The company has 2 employees (2026). In 2024, the company reported a gross profit of DKK -255,949 and a net result of DKK 4,003,809 compared with DKK 2,462,806 the year before. Equity in the 2024 report amounted to DKK 44,842,105.